Total Funding
9
23
Total FundingVenture - Series Unknown raised
Growth Score
-9 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
694638
InCytu develops anticancer immunotherapies that use the patient's own immune system to selectively target and destroy tumor cells.
Alfred Vasconcellos: President and CEO
About the Company
InCytu is a therapeutic device engineering company developing immunotherapeutic and tissue regeneration products to transform personalized medicine. Founded in 2007 and lead by a strong management team, the cornerstone of InCytu's transformative technology platform was developed by Prof. David Mooney at Harvard University. The Company's
first products revolve around the Cellarium™ system, a family of intelligent bioresorbable materials which are formulated and programmed to manipulate the immune system or rapidly heal and regenerate damaged or diseased tissue.
